BioSpace News Archive

Simplify Medical, Inc., a privately-held company focused on cervical spinal disc arthroplasty and developer of the Simplify® Cervical Artificial Disc, today announced its first surgery following the recent FDA approval for 1-level use.

Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, today announced that John Maxwell, Senior Vice President, Chief Financial Officer (CFO) of the Company,

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced initial findings from the company’s research collaboration with Labcorp that is focused on SARS-CoV-2 and the related immune response to COVID-19. Announced in April 2020 , PacBio and Labcorp are collaborating to develop a production-scale assay for sequencing the complete genome

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced outstanding clinical results for its total hip arthroplasty (THA) portfolio in both the National Joint Registry for England, Wales and Northern Ireland (NJR) and the the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR

Medtronic plc (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has cleared the use of navigated interbody and Midas Rex™ high speed drills with the Mazor™ Robotic Guidance System earlier than originally anticipated.

Blue Cross Blue Shield of Massachusetts (“Blue Cross”) today announced two new initiatives designed to provide additional support to members living with substance use disorder. The company has contracted with AWARE

Emedgene, a leading precision medicine intelligence company, announces a non-exclusive partnership with Illumina Inc. and the integration of automated interpretation into Illumina’s TruSight™ Software Suite for rare genetic diseases

Pall Corporation, a global leader in filtration, separation and purification, announced a strategic partnership with Single Use Support GmbH, a leading provider of an innovative, end-to-end solution for safe handling of biologics from bulk manufacturing to fill finish

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“the “Company”) today announced that on December 15, 2020, it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq’s minimum bid price requirement and is in compliance with all applicable listing standards.

Genosity , Inc, a biotechnology company offering novel software and laboratory solutions to enable development and deployment of complex NGS assays, announced an agreement with Gemini Therapeutics to conduct molecular profiling in support of clinical trial patient selection and stratification for Gemini’s GEM103 program in age-related macular degeneration (AMD). Under this agreement, Gemini will provide samples from prosp